Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


Parallel Trade

06 Feb 2013 - 07 Feb 2013 - London, UK



Bookmark and Share


SMi are proud to present their 7th annual Parallel Trade conference. 

Our 2013 agenda will showcase the latest developments in pharmaceutical Parallel Trade, looking at the industry’s rapid expansion and latest arguments from key opinion leaders on this controversial industry. Hear from experts in leading industry sectors; see how big Pharma companies are beginning to combat traders and attempt to prevent counterfeit medicines entering the market. Through case studies see how trading can affect future R&D pipelines in big pharma drug development. Parallel trade has unique, important legal issues attached to it – hear from specialist pharmaceutical lawyers explaining issues with intellectual property and specific aspects of repackaging. 

Reasons why you should attend:

Hear from the industry leaders on both the advantages and disadvantages to patients, drug producers and traders. How does trading affect your business – New market access or potential hazard? 

See how parallel trade is being maintained from both sides of the fence, supply chain protection and specific aspects of repackaging.

Learn how the financial euro crisis has allowed an increase in need for more affordable drugs to supply harder hit countries but also put an increased pressure on pharmaceutical companies who pay for drug development.

Visit our website here: http://www.smi-online.co.uk/2013paralleltrade12.asp

Alternatively Contact Fateja Begum on telephone +44 (0) 20 7827 6184 or email on fbegum@smi-online.co.uk

Quote “Technology Network” and save £100




Further information
Scientific News
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
Study to Assess Shorter-Duration Antibiotics in Children
Physicians plan a clinical trial to evaluate whether short course anti-biotics are effective at treating CAP in children.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
Cancer Gene Predicts Treatment Response in Leukaemia
Study indicates the patients suffering from a lethal for of acute myeloid leukemia may live longer when receiving milder chemotherapy drugs.
Injectable Biologic Therapy Reduces Triglycerides
Study finds first-of-its-kind therapy promising for patients with high triglycerides, cholesterol.
Testing Zika Vaccine in Humans Begins
The first of five planned clinical trials to test ZPIV vaccine in humans has begun.
Combination Therapy Improved Chemoresistance in Ovarian Cancer
The study demonstrates how an existing class of targeted therapies could be used to potentiate the tumor suppression induced by cisplatin.
Gene Therapy for Blistering Skin Disease Shows Promise
Grafting genetically altered skin onto patients’ chronic wounds marks the first time skin-based gene therapy has been demonstrated to be safe and effective in humans.
Alzheimer’s Treatment Moves a Step Closer
Merck scientists have reported the discovery of verubecestat, a structurally unique, orally bioavailable small molecule that has been shown to target the most visible sign of the disease in the brain.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!